Tag: Cross-Contamination

Shared Facility Risk Assessment for Product Introduction

Assessing Risks in Shared Facilities for Product Introduction In the pharmaceutical industry, shared facilities often pose complex challenges when introducing new products. The risks associated with cross-contamination, inadequate segregation, and…

Cleaning and Cross-Contamination CAPA Effectiveness Verification

Effective Verification of CAPA for Cleaning and Cross-Contamination Issues In the pharmaceutical manufacturing environment, contending with cleaning and cross-contamination deviations is a critical aspect of maintaining product integrity and compliance…

How to Qualify Shared Equipment for Multiple Products

Effective Strategies for Qualifying Shared Equipment Across Multiple Products In a landscape where cross-contamination risks in shared facilities loom large, professionals in pharmaceutical manufacturing must devise effective strategies to ensure…

Cross-Contamination Risk from Incomplete Equipment Disassembly

Addressing Cross-Contamination Risks Due to Inadequate Equipment Disassembly In pharmaceutical manufacturing, the risk of cross-contamination poses significant challenges, particularly due to incomplete equipment disassembly during cleaning processes. This issue can…

Shared Facility Change Control Triggers for New Products

Effective Management of Change Control Triggers in Shared Facilities for New Product Introductions As pharmaceutical companies increasingly utilize shared facilities, the potential for cross-contamination and subsequent product integrity issues has…

Shared Facility Change Control Triggers for New Products

Identifying and Addressing Change Control Triggers in Shared Facilities for New Products Implementing new products in a shared facility presents unique challenges, particularly in terms of contamination control and compliance…

Cleaning Deviation Caused by Wrong Equipment Status Label

Addressing Cleaning Deviations Due to Incorrect Equipment Status Labels In pharmaceutical manufacturing, accurate cleaning protocols are essential for ensuring product safety and compliance with GMP (Good Manufacturing Practices). A common…

Shared Facility Risk Controls for Antibiotics and Sensitizers

Effective Controls for Risk Management in Shared Facilities Handling Antibiotics and Sensitizers In the context of pharmaceutical manufacturing, shared facilities that produce antibiotics and sensitizers face unique challenges. The prominent…

How to Strengthen Cleaning SOPs After Cross-Contamination Deviations

Strengthening Cleaning Standard Operating Procedures (SOPs) After Cross-Contamination Deviations In the sphere of pharmaceutical manufacturing, maintaining cleanliness standards is paramount. Cross-contamination deviations can pose significant risks to product integrity, leading…

Shared Facility Risk Management for Low-Dose Products

Effective Risk Management Strategies for Shared Facility Operations in Low-Dose Pharmaceutical Production In the complex landscape of pharmaceutical manufacturing, particularly within shared facilities handling low-dose products, the risk of cross-contamination…